SGHT - NASDAQ

Sight Sciences, Inc.

Sight Sciences, Inc.

SGHTยทNASDAQ

$4.55

+4.8%
HealthcareMedical - Devices

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$247.57M
EPS-0.7400
P/E Ratio-6.15
Earnings Date08/06/2026
Sight Sciences, Inc.

Sight Sciences, Inc. Fair Value Envelope

SGHT ยท NASDAQ

Our analysis suggests that SGHT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.55, this represents a potential HIDDEN relative to our calculated worth for Sight Sciences, Inc..

HIDDEN
Intrinsic Value
Current Price: $4.55

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value-$50.9M
+ Cash & Equivalents$92.0M
Firm Value$41.1M
- Debt$40.8M
Equity Value$334.2K
/ Shares Outstanding52,367,359B
DCF Value$0
OVERVALUED BY 100%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
-$20.3M
-$13.9M
-$9.5M
-$6.5M
-$4.4M
-$3.0M
-$2.1M
-$1.4M
-$974.6K
-$666.7K
Maintenance CapEx
-$30.6K
-$21.0K
-$14.3K
-$9.8K
-$6.7K
-$4.6K
-$3.1K
-$2.1K
-$1.5K
-$1.0K
Owner Earnings
-$20.3M
-$13.9M
-$9.5M
-$6.5M
-$4.5M
-$3.0M
-$2.1M
-$1.4M
-$976.1K
-$667.7K
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
-$18.8M
-$11.9M
-$7.6M
-$4.8M
-$3.0M
-$1.9M
-$1.2M
-$770.8K
-$488.3K
-$309.3K
Terminal Value represents 0.0% of Enterprise Value
Negative Owner Earnings
This company generates negative free cash flow. Consider adjusting maintenance CapEx percentage or check the financial data.

Related Guides

Blog Categories

Continue your SGHT research with focused valuation guides.

DCF Modeling

Improve assumptions for intrinsic value accuracy.

Forecasting

Calibrate growth paths and terminal value behavior.

WACC

Refine discount-rate logic for valuation quality.

Cost of Capital

Match risk profile to expected return assumptions.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.